FDA.reportPublic FDA data

Brukinsa 80 MG Oral Capsule

RxCUI
2262446
RxNorm name
Brukinsa 80 MG Oral Capsule
Display name
Brukinsa 80 MG Oral Capsule
Full name
Brukinsa 80 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BRUKINSAZANUBRUTINIBBeOne Medicines USA, Inc.3e08fe23-d70e-424c-bc51-1222e320f9022026-07-21Warnings, Adverse reactionsExact identifier
rxcui: 2262446

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3e08fe23-d70e-424c-bc51-1222e320f902Brukinsa 80 MG Oral Capsule [PSN] · zanubrutinib 80 MG Oral Capsule [Brukinsa] [SBD] · Brukinsa 80 MG Oral Capsule [SY]322These highlights do not include all the information needed to use BRUKINSA safely and effectively. See full prescribing information for BRUKINSA. BRUKINSA ® (zanubrutinib) capsules, for oral use BRUKINSA ® (zanubrutinib) tablets, for oral use Initial U.S. Approval: 201920260202